Author

Ginger Gillette-Kent

Observed name: G. Gillette-Kent

Institutions: Mayo Clinic, Mayo Clinic in Arizona

Observed institutions: Mayo Clinic, Mayo Clinic in Arizona, Mayo Clinic Hospital

OpenAlex ID: A5022509986

Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase

2012 · Chad Cherington, James L. Slack, et al. · Leukemia Research · 45

In-Vivo T-Cell Depletion with Rabbit Anti-Thymocyte Globulin (r-ATG) Prevents Severe Acute and Chronic Graft Versus Host Disease (GVHD) and Allows Safe Allogeneic Stem Cell Transplantation (allo-SCT) From Mismatched, Unrelated Donors

2011 · James L. Slack, Jose F. Leis, et al. · Blood

Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML): Low Incidence of Relapse and Graft Versus Host Disease (GVHD) in Patients (pts) Transplanted without Active Leukemia Using in-Vivo T-Cell Depletion with Rabbit Anti-Thymocyte Globulin (r-ATG)

2011 · James L. Slack, Jose F. Leis, et al. · Blood

Induction Therapy Followed by Allogeneic Stem Cell Transplant for MPN Blast Phase: Outcomes From Mayo Clinic in Arizona

2011 · Chad Cherington, James L. Slack, et al. · Blood

In-Vivo T-Cell Depletion Using Thymoglobulin (Thymo) Allows Successful Allogeneic Stem Cell Transplantation (Allo-SCT) From Mismatched, Unrelated Donors (MM-URD): Potential Influence Of Graft Source On Outcome

2010 · J.L. Slack, J.F. Leis, et al. · Transplantation and Cellular Therapy

Works count: 5

Citation count: 45

H-index: 1

I10-index: 1